Patents-Review.com
ClassID:

110166 ⎘

C12N2720/12334 - CPC Classification

Classification description:

dsRNA viruses; Details; Reoviridae; Rotavirus, e.g. rotavirus A Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260000749
2026-01-01

ROTAVIRUS VACCINES

 #2
20250276053
2025-09-04

ROTAVIRUS VACCINES

 #3
20250263443
2025-08-21

RECOMBINANT ROTAVIRUS EXPRESSING EXOGENOUS PROTEIN AND USES THEREOF

 #4
20250171502
2025-05-29

RECOMBINANT ROTA VIRUS EXPRESSION SYSTEM AND RECOMBINANT ROTA VIRUSES

 #5
20250011730
2025-01-09

NOVEL PORCINE ROTAVIRUS

 #6
20240358825
2024-10-31

Novel Adjuvant Compositions

 #7
20240000918
2024-01-04

Rotavirus vaccines

 #8
20230190911
2023-06-22

VACCINE FORMULATIONS WITH INCREASED STABILITY

 #9
20230128782
2023-04-27

Rotavirus vaccines

 #10
20220347295
2022-11-03

Vaccine delivery method

 #11
20220313813
2022-10-06

ROTAVIRUS MRNA VACCINE

 #12
20220220452
2022-07-14

Porcine rotavirus

 #13
20220002350
2022-01-06

Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine

 #14
20210338810
2021-11-04

Adjuvant compositions

 #15
20210308254
2021-10-07

Human rotavirus strains and vaccines

 #16
20210269488
2021-09-02

Recombinant rotavirus expression system and recombinant rotaviruses

 #17
20210145751
2021-05-20

Method for preserving biopharmaceuticals

 #18
20210015916
2021-01-21

Vaccine delivery method

 #19
20200308233
2020-10-01

Truncated rotavirus VP4 protein and application thereof

 #20
20200121782
2020-04-23

Thermal inactivation of rotavirus

 #21
20200054735
2020-02-20

Human rotavirus strains and vaccines

 #22
20200009242
2020-01-09

Heat stable vaccines

 #23
20190275136
2019-09-12

VACCINE FORMULATIONS WITH INCREASED STABILITY

 #24
20190175729
2019-06-13

Compositions

 #25
20190175722
2019-06-13

Multivalent vaccine composition

 #26
20190160164
2019-05-30

Rotavirus vaccines

 #27
20190142932
2019-05-16

Buffer free, acid stable low dose volume rotavirus vaccine

 #28
20190008953
2019-01-10

Adjuvant compositions

 #29
20190000957
2019-01-03

Thermally stable rotavirus vaccine formulations and methods of use thereof

 #30
20180346884
2018-12-06

MODIFIED HUMAN ROTAVIRUSES AND USES THEREFOR

 #31
20180333499
2018-11-22

Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids

 #32
20180236060
2018-08-23

Human rotavirus vaccine strains and diagnostics

 #33
20180228889
2018-08-16

Heat stable liquid rotavirus vaccine

 #34
20180141978
2018-05-24

Truncated rotavirus VP4 protein and application thereof

 #35
20180028644
2018-02-01

Thermal inactivation of rotavirus

 #36
20180016561
2018-01-18

Rotavirus-like particle production in plants

 #37
20170304434
2017-10-26

Adjuvant compositions

 #38
20170258899
2017-09-14

Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same

 #39
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #40
20170173145
2017-06-22

Thermostable spray dried rotavirus vaccine formulation and process thereof

 #41
20170173144
2017-06-22

Human rotavirus vaccine strains and diagnostics

 #42
20170165354
2017-06-15

Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

 #43
20170095563
2017-04-06

Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids

 #44
20160252300
2016-09-01

Method of microwave vacuum drying spherical-shaped pellets of biological materials

 #45
20160228540
2016-08-11

Nasal mucosal vaccine composition

 #46
20160213773
2016-07-28

Mucosal vaccine composition

 #47
20160193327
2016-07-07

Mucosal vaccine composition

 #48
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #49
20160145583
2016-05-26

Methods for preparing inactivated rotavirus

 #50
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #51
20150337268
2015-11-26

Modified human rotaviruses and uses therefor

 #52
20150252334
2015-09-10

Method for in-vitro preparation of double-layered virus-like particles of rotavirus

 #53
20150216961
2015-08-06

ROTAVIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

 #54
20150098967
2015-04-09

Rotavirus vaccine compositions and process for preparing the same

 #55
20150079122
2015-03-19

Human rotavirus vaccine strains and diagnostics

 #56
20140056940
2014-02-27

Adjuvant compositions

 #57
20140017269
2014-01-16

Protein complex system for increased immunogenicity and functionality, and methods making and use

 #58
20130280293
2013-10-24

Combination heptavalent vaccine

 #59
20130273090
2013-10-17

Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use

 #60
20130216567
2013-08-22

Avian group D rotavirus

 #61
20130209507
2013-08-15

Rotavirus subunit vaccines and methods of making and use thereof

 #62
20130058969
2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

 #63
20120252727
2012-10-04

Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids

 #64
20120237547
2012-09-20

Live attenuated rotavirus vaccine for oral administration

 #65
20120148570
2012-06-14

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE-CHALLENGED ANIMALS

 #66
20120121629
2012-05-17

Human rotavirus vaccine strains and diagnostics

 #67
20120107356
2012-05-03

Composition useful as rotavirus vaccine and a method therefor

 #68
20120093884
2012-04-19

Norovirus capsid and rotavirus VP6 protein for use as combined vaccine

 #69
20110311573
2011-12-22

Method for preparing recombinant antigen complex using rotavirus nanoparticle

 #70
20110305768
2011-12-15

QUICK-DISSOLVING ORAL THIN FILM FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

 #71
20110177119
2011-07-21

Stable, dried rotavirus vaccine, compositions and process for preparation thereof

 #72
20110177116
2011-07-21

Methods of immunizing pregnant heifers at three months of gestation

 #73
20110171316
2011-07-14

Expression and assembly of human group C rotavirus-like particles and uses thereof

 #74
20110104200
2011-05-05

Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines

 #75
20110033493
2011-02-10

VACCINE

 #76
20100322962
2010-12-23

Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use

 #77
20100266628
2010-10-21

Macrocyclic lactone combination compositions, vaccines and methods for producing same

 #78
20100226939
2010-09-09

Formulations for preservation of rotavirus

 #79
20100215667
2010-08-26

METHODS AND COMPOSITIONS OF TREATMENT FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS

 #80
20100209455
2010-08-19

Thermal inactivation of rotavirus

 #81
20100196919
2010-08-05

PEPTIDES, ANTIBODIES AND FRAGMENTS THEREOF FOR THE TREATMENT AND DIAGNOSTIC OF CELIAC DISEASE

 #82
20100068227
2010-03-18

Stabilized liquid rotavirus vaccine composition

 #83
20100047278
2010-02-25

Human rotavirus and vaccine composition comprising same

 #84
20100028371
2010-02-04

Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals

 #85
20100008951
2010-01-14

Flu vaccine admixture of mannan and flu antigen

 #86
20090324641
2009-12-31

Adjuvant compositions

 #87
20090136545
2009-05-28

PORCINE ROTAVIRUS REASSORTANT COMPOSITIONS

 #88
20090130145
2009-05-21

Homogeneous attenuated human rotavirus population

 #89
20090081256
2009-03-26

TRANSGENIC PLANT-BASED VACCINES

 #90
20090028828
2009-01-29

Rotavirus Vaccine Inducing Heterotypic Cross Protection

 #91
20080317776
2008-12-25

Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor

 #92
20080292660
2008-11-27

Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

 #93
20080274143
2008-11-06

Chloroplasts Engineering to Express Pharmaceutical Proteins

 #94
20080213263
2008-09-04

METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE DYSFUNCTION DISORDERS

 #95
20080199491
2008-08-21

Sustained release vaccine composition

 #96
20080187553
2008-08-07

Immunstimulating lipid formulation

 #97
20080166372
2008-07-10

Live attenuated rotavirus vaccine for oral administration

 #98
20080138340
2008-06-12

METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS

 #99
20080063662
2008-03-13

VACCINE

 #100
20080057082
2008-03-06

Immunogenic composition of a homogeneous live attenuated human rotavirus population

 #101
20070020282
2007-01-25

Immunstimulating lipid formulation

 #102
20060286109
2006-12-21

Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen

 #103
20060277635
2006-12-07

Transgenic plant-based vaccines

 #104
20060140976
2006-06-29

Trivalent vaccine with maternal anitbody transfer via the milk

 #105
20050281842
2005-12-22

Inactivated bovine scours vaccines, process and method of preventing bovine scours

 #106
20050271674
2005-12-08

Methods and compositions for modulating the immune system of animals

 #107
20050130127
2005-06-16

Coronavirus-like particles comprising functionally deleted genomes

 #108
20050075298
2005-04-07

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

 #109
20050048083
2005-03-03

Immunization with an attenuated human rotavirus

 #110
20050037085
2005-02-17

Microencapsulated DNA for vaccination and gene therapy